Sectra Expands AI Solutions to Optimize Pathology Services

Sectra Expands AI Solutions to Optimize Pathology Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has recently established an agreement with Paige.AI, a vendor specializing in AI for pathology. This partnership aims to revolutionize the healthcare landscape by enabling pathologists to access AI applications through a single contract, thus simplifying the entire implementation and support process.
According to Nynke Breimer, Global Product Manager for Amplifier Services at Sectra, the company is deeply committed to enhancing cancer care. This new offering represents a significant step toward creating a unified solution that aligns imaging requirements across various medical specialties, including radiology, pathology, and genomics. Such integration is essential for optimizing cancer diagnostics and promoting collaborative efforts among healthcare providers.
Breimer emphasizes that there are notable barriers to the clinical adoption of AI within the healthcare sector. However, the collaboration with Paige, combined with an ongoing project with Region Skåne, showcases Sectra's commitment to overcoming these challenges and paving the way for effective pathology AI applications. This project serves as a foundational step in implementing AI in real-world clinical settings.
In early 2025, Region Skåne launched a proof-of-concept initiative focusing on the Paige Prostate Suite within their pathology workflows. This innovative approach integrates AI technology to enhance diagnostic efficiency by providing pathologists with automated results. This collaboration aims to create applicable insights that can facilitate other AI implementations both within and beyond Region Skåne, with a goal of improving cancer care standards.
Kevin Sandeman, Head of Digital Pathology Development at Region Skåne, points out that prostate cancer represents a high-volume diagnostic challenge. The robust workflows and availability of CE-marked AI tools make it an ideal starting point for proof-of-concept efforts, allowing healthcare teams to explore real-world applications of AI while ensuring safety and effectiveness in cancer diagnostics.
The Sectra Amplifier Service delivers a fully managed AI platform accessible via the cloud. This offering streamlines the entire process, taking full responsibility for workflow management, integration, deployment, and ongoing support. By centralizing AI applications within a single infrastructure, healthcare providers can avoid the complexities and security risks associated with managing multiple systems.
The distribution agreement signed with Paige reinforces Sectra's dedication to providing cutting-edge AI services. By acting as a reseller for the Paige Prostate Suite through their Amplifier Service, Sectra continues to lead innovation in healthcare technology solutions.
Sectra’s Amplifier Service is designed to be part of its expansive enterprise imaging solution, which aims to consolidate all imaging needs into one cohesive system. This innovative approach not only enhances medical outcomes but also helps reduce operational expenditures. The scalable and modular nature of this solution allows healthcare providers to adapt and grow without the need for new backend systems.
Founded in 1978 and headquartered in Linköping, Sectra has been instrumental in promoting a more efficient global healthcare system. The company serves health systems around the world and plays a vital role in safeguarding sensitive information for defense forces. With a reported revenue of SEK 2,964 million for the 2023/2024 fiscal year, Sectra's commitment to enhancing healthcare technology is evident. The Sectra share is publicly traded on the Nasdaq Stockholm exchange.
About Sectra
Sectra is dedicated to fostering a healthier society by helping health authorities optimize their care efficiency. With sales operations in 19 countries and international distribution partners, Sectra’s global presence is pivotal in driving advancements in medical imaging IT and cybersecurity. For further information about Sectra and its award-winning solutions, visit their official website.
For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10
Frequently Asked Questions
What is Sectra's new partnership about?
Sectra has partnered with Paige.AI to provide AI applications specifically for pathology, enhancing diagnostic capabilities through a unified platform.
How does the Sectra Amplifier Service work?
The Sectra Amplifier Service delivers a fully managed AI platform via the cloud, handling all aspects of workflow from deployment to support.
What benefits does AI integration offer in pathology?
AI integration facilitates automated diagnostic processes, which improves accuracy and efficiency, allowing pathologists to focus on critical analysis.
Where is Sectra headquartered?
Sectra is headquartered in Linköping, Sweden. The company operates in multiple countries worldwide.
How can I learn more about Sectra's services?
For further information about Sectra and their innovative solutions, please visit their official website to explore their offerings.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.